Sewickley Academy’s Post

📣 Exciting news! Our latest paper on the impact of reduced [18F]FDG doses in whole-body PET/CT imaging has been published and is now accessible in the journal Frontiers in Physics. Take a look and share your insights with us 💡

From academia to medical innovation - why a multidisciplinary approach is key It is the interaction between different research areas, disciplines, and healthcare areas that leads to interesting observations. Erasmus MC acts at the forefront of this multidisciplinary approach. “With the neuroscience division, the transplantation people or with the intensive care unit from Professor Gommers, it is very multidisciplinary here and many divisions apply and use our technologies.” Go Behind the Science! Professor Peter J. van der Spek reveals how AI is transforming cancer care. Watch the full interview: https://lnkd.in/eSnyrEMh #RotterdamGenomics #LifeSciences #DNAResearch #MedicalInnovation #Collaboration #kadans

From academia to medical innovation - why a multidisciplinary approach is key It is the interaction between different research areas, disciplines, and healthcare areas that leads to interesting observations. Erasmus MC acts at the forefront of this multidisciplinary approach. “With the neuroscience division, the transplantation people or with the intensive care unit from Professor Gommers, it is very multidisciplinary here and many divisions apply and use our technologies.” Go Behind the Science! Professor Peter van der Spek reveals how AI is transforming cancer care. Watch the full interview: https://lnkd.in/eSnyrEMh #RotterdamGenomics #LifeSciences #DNAResearch #MedicalInnovation #Collaboration

🌟 Postdocs are the unsung heroes of research integrity, playing a vital role in shaping a healthy research culture.    🔬 In the latest #ResearchIntegrity column, Andrew Porter from the Cancer Research UK Manchester Institute explores the crucial role postdocs play in contributing to research integrity. From training new lab members and embracing open science practices to championing transparency in methodology, postdocs provide much of the fabric that underpins research integrity 💡    Read the full blog 👉 https://bit.ly/3TxvTla

In this episode of Research Renaissance, Dr. Ignaty Leshchiner, a pioneer in computational biology and cancer bioinformatics, explores the intricate relationship between cancer research and brain disease studies. His insights delve into groundbreaking methodologies for non-invasive cancer detection, the challenges in treating brain tumors, and the potential for early diagnosis of neurological diseases, such as Alzheimer's, through advanced blood tests. Boston University School of Medicine Listen, Like, Download and Share at Apple Podcast, Spotify, Amazon Music, and iHeartRadio. #Reserach #Future #Science #Alzheimers

Are you a cancer biologist, developmental biologist or a neuroscientist interested in cell communities? In the latest #insilicotalk, SIB Member Marco Varrone takes you through CellCharter, a computational framework designed to uncover and analyze communities of cells within tissues, which has been recently selected among the #SIBRemarkableOutputs 2023.   👉 Watch it here: https://lnkd.in/e8x7A7Bp   #bioinformaticstraining #spatialcellsniches #spatialtranscriptomics #insilicotalks 💡 in silico talks are short videos in which SIB scientists present the latest in bioinformatics. Find previous videos and subscribe to be notified of upcoming ones here: https://lnkd.in/egXvMqTF University of Lausanne - UNIL Daniele Tavernari Ludwig Cancer Research CHUV | Lausanne university hospital

“How can we apply this advanced AFM-based method that we develop to understand disease progression? If it's cancer, if it's hearing, or if it's inflammation.” Our latest research highlight features Alexander Cartagena-Rivera, Ph.D., the Chief of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Section on Mechanobiology. In his interview with Melissa Martin, Dr. Cartagena-Rivera discusses the two main divisions of his lab which focus on developing #AFM methods depending on the type of sample and how these methods can help us better understand disease progression and therapeutics. Dr. Cartagena-Rivera is also a member of the NIH Distinguished Scholars program for underrepresented minorities at the National Institute of Health and actively works to analyze the large datasets from AFMs in an unbiased way by considering age, gender, ethnicity, etc. Check it out below to learn more about Dr. Cartagena’s efforts in the lab, ongoing experiments in the clinic, and exciting new opportunities to use AFM technology as a point-of-care tool for people. #cancer #ResearchHighlight

During my PhD, mistakes have been like unexpected teachers, showing me important lessons: 1. Failed experiments taught me patience and the promise of success from setbacks. 2. Wrong turns in protocols honed my attention to detail and the value of double-checking each step. 3. Challenging days fostered resilience, teaching me to navigate the flow of research. Here's to the mistakes—the unsung heroes shaping not just my research in Cancer Biology, but also the resilience woven within setbacks. #PhDMistakes #ResearchLessons

George Goshua, MD, MSc, Assistant Professor of Medicine (Hematology), recently traveled to Zurich, Switzerland to accept the prestigious NOMIS Foundation and Science Magazine Young Explorer Award. The award acknowledges three young and creative researchers across the globe who take bold risks to ask fundamental questions at the intersection of life and social sciences and who have made significant advances in applying techniques developed in one domain to address questions in another.   Dr. Goshua’s award-winning essay published in Science, "Napkin math can change the world," uncovers how mathematical models can hold the key to equitable patient care.   Read more about Dr. Goshua and research at Yale Cancer Center: https://lnkd.in/eXDG_zNJ.

This week on A4LI’s Scientist Spotlight, we get to chat with Ivan A. Salladay-Perez, a fourth year PhD student studying immunosenescence in the Covarrubias lab at the David Geffen School of Medicine at UCLA. In this episode, we discuss what inspired him to pursue science and his journey in fully grasping aging biology with his cancer biology background. You can listen to our full discussion here: https://lnkd.in/gRYnCAEi.